Meanwhile, four patients (12.9%) had DTA-related CH mutations in more than one gene (3 DNMT3A + TET2, 1 DNMT3A + ASXL1), while two patients with CH had two mutations in the same gene (1 DNMT3A, 1 TET2). This evidence concerns the gene DNMT3A and cyclic hematopoiesis.